Publisher
Springer International Publishing
Reference38 articles.
1. Bast, C. R., Ravdin, P., Hayes, D. F., Bates, S., Fritsche, H., Jessup, J., Kemeny, N., Locker, G. Y., Mennel, R. G., & Mark, R. (2001). 2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: Clinical practice guidelines of the American Society of Clinical Oncology. Journal of Clinical Oncology, 19(6), 1865–1878.
2. Botti, C., Pescatore, B., Mottolese, M., Sciarretta, F., Greco, C., Di Filippo, F., Gandolfo, G. M., Cavaliere, F., Bovani, R., Baranese, A., & Cianciulli, A. M. (2000). Incidence of chromosome 1 and 17 aneusomy in breast cancer and adjacent tissue: An interphase cytogenetic study. Journal of the American College of Surgeons, 190(5), 530–539.
3. Dal Cin, P., & Van den Berghe, H. (1997). Bone and soft tissue tumors. Cancer Genetics and Cytogenetics, 95, 59–66.
4. Di Leo, A., Dowsett, M., Horten, B., & Penault-Llorca, F. (2002). Current status of Her2 testing. Oncology, 63, 25–32.
5. Farabegoli, F., Santini, D., Maccarelli, C., Taffurelli,. M., Marrano, D., Baldini, N. (2001). Clone heterogeneity in diploid and aneuploid breast carcinomas as detected by FISH. Cytometry 46:50–56.